Syndax Pharmaceuticals (SNDX) Short term Debt (2020 - 2024)
Syndax Pharmaceuticals (SNDX) posted quarterly Short term Debt of $12.1 million for Q4 2024, up 68.0% quarter-over-quarter from $7.2 million in Q2 2022.
Syndax Pharmaceuticals (SNDX) Short term Debt (2020 - 2024) Analysis & Trends
Syndax Pharmaceuticals' Short term Debt history runs 4 years deep, the most recent figure standing at $12.1 million for Q4 2024.
- In Q4 2024, Short term Debt changed N/A year-over-year to $12.1 million; the TTM figure through Dec 2024 stood at $12.1 million (changed N/A YoY), while the FY2024 annual figure was $12.1 million, changed N/A from the prior year.
- Short term Debt for Q4 2024 stood at $12.1 million, up from $7.2 million in the prior quarter.
- The five-year high for Short term Debt was $12.1 million in Q4 2024, with the low at $2.3 million in Q4 2020.
- The 4-year median for Short term Debt is $7.0 million (2021), against an average of $6.6 million.
- Peak annual rise in Short term Debt reached 2.59% in 2022, while the deepest fall reached 22.97% in 2022.
- Syndax Pharmaceuticals' Short term Debt stood at $2.3 million in 2020, then jumped by 315.27% to $9.5 million in 2021, then decreased by 24.0% to $7.2 million in 2022, then soared by 68.0% to $12.1 million in 2024.
- Business Quant data shows SNDX's Short term Debt at $12.1 million in Q4 2024, $7.2 million in Q2 2022, and $3.6 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Syndax Pharmaceuticals | 1.77 Bn | 1.22 Bn | 60.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 12.12 Mn |
| Jun 30, 2022 | 7.21 Mn |
| Mar 31, 2022 | 3.57 Mn |
| Sep 30, 2021 | 9.49 Mn |
| Jun 30, 2021 | 7.03 Mn |
| Mar 31, 2021 | 4.63 Mn |
| Dec 31, 2020 | 2.29 Mn |